The document discusses exacerbation of heart failure with the use of thiazolidinediones, providing an overview of heart failure, insulin resistance, and the mechanisms of fluid retention associated with thiazolidinediones based on case reports and clinical trial data. It also reviews guidelines for managing patients with diabetes and heart failure, and recommends alternative anti-diabetic agents or cautious use of thiazolidinediones.
John B. Buse, MD, PhD; David Cherney, MD, PhD, FRCP(C); and Mikhail Kosiborod, MD, FACC, FAHA, prepared useful Practice Aids pertaining to SGLT2 inhibitors for this CME activity titled “Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases.” For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at https://bit.ly/3dFKZhs. CME credit will be available until July 22, 2021.
Definition & incidence of Hypertension
Classification of Hypertension
Diagnosis/ Confirmation of Hypertension
Technique of Hypertension Measurement
White coat Hypertension
Type of Hypertension
Suspicion of secondary hypertension
Management of Hypertension(Stage 1& 2)
Why treatment is necessary
Life style modification
Drug treatment of Hypertension
Rationalae of combination
Hypertension management in special situation/ with complications
Indications of ARBs
Mechanism of action of ARBs
Comparison of different ARBs-pharmacology, efficacy
Safety of ARBs-Recall, Malignancy
Study on Telmisartan
Management of CAD in Diabetes the cardiovascular equivalent is challenging.The slides take you from the epidemiology,ADD,and CV benefit and how to manage CAD
John B. Buse, MD, PhD; David Cherney, MD, PhD, FRCP(C); and Mikhail Kosiborod, MD, FACC, FAHA, prepared useful Practice Aids pertaining to SGLT2 inhibitors for this CME activity titled “Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases.” For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at https://bit.ly/3dFKZhs. CME credit will be available until July 22, 2021.
Definition & incidence of Hypertension
Classification of Hypertension
Diagnosis/ Confirmation of Hypertension
Technique of Hypertension Measurement
White coat Hypertension
Type of Hypertension
Suspicion of secondary hypertension
Management of Hypertension(Stage 1& 2)
Why treatment is necessary
Life style modification
Drug treatment of Hypertension
Rationalae of combination
Hypertension management in special situation/ with complications
Indications of ARBs
Mechanism of action of ARBs
Comparison of different ARBs-pharmacology, efficacy
Safety of ARBs-Recall, Malignancy
Study on Telmisartan
Management of CAD in Diabetes the cardiovascular equivalent is challenging.The slides take you from the epidemiology,ADD,and CV benefit and how to manage CAD
La aterosclerosis como enfermedad sistémica una visión integral de la enfermedad cardiovascular
Miércoles, 22/06/16 18:00h-20:00h Casa del Corazón, Madrid
http://cvvt.secardiologia.es
#CVVT
La enfermedad aterosclerótica en cardiología: particularidades y novedades
Dr. Leopoldo Pérez de Isla. Hospital Universitario Clínico San Carlos, Madrid
Prevention of recurrent stroke in atrial fibrillation Jacek StaszewskiJacek Staszewski
Prevention of recurrent stroke in atrial fibrillation. Comaprison of NOAC vs VKA. Riks of hemorrhagic stroke. When anticoagulation should be initiated following acute stroke.
Reduciendo eventos cardiovasculares en pacientes con DM2: nuevas evidencias
23/06/16 18:00h Casa del Corazón, Madrid
http://ecvdm2.secardiologia.es
#ECVDM2
Resultados de nuevos estudios: más allá de la no inferioridad
Dr. Luis Masmiquel Comas, Endocrinólogo. Hospital Son Llàtzer (Palma de Mallorca)
Hurdles and new players in the management of chronic heart failure with reduc...Dhritisdiary
Watch the slideshow for a better understanding: https://youtu.be/CsXvS1hA330
1. Learn the standard therapy in HFrEF
2. Learn its challenges
3. Learn the new drugs for HFrEF.
La aterosclerosis como enfermedad sistémica una visión integral de la enfermedad cardiovascular
Miércoles, 22/06/16 18:00h-20:00h Casa del Corazón, Madrid
http://cvvt.secardiologia.es
#CVVT
La enfermedad aterosclerótica en neurología: particularidades y novedades
Dr. Carlos Molina Cateriano, Hospital Universitari Vall d'Hebron, Barcelona
La aterosclerosis como enfermedad sistémica una visión integral de la enfermedad cardiovascular
Miércoles, 22/06/16 18:00h-20:00h Casa del Corazón, Madrid
http://cvvt.secardiologia.es
#CVVT
La enfermedad aterosclerótica en cardiología: particularidades y novedades
Dr. Leopoldo Pérez de Isla. Hospital Universitario Clínico San Carlos, Madrid
Prevention of recurrent stroke in atrial fibrillation Jacek StaszewskiJacek Staszewski
Prevention of recurrent stroke in atrial fibrillation. Comaprison of NOAC vs VKA. Riks of hemorrhagic stroke. When anticoagulation should be initiated following acute stroke.
Reduciendo eventos cardiovasculares en pacientes con DM2: nuevas evidencias
23/06/16 18:00h Casa del Corazón, Madrid
http://ecvdm2.secardiologia.es
#ECVDM2
Resultados de nuevos estudios: más allá de la no inferioridad
Dr. Luis Masmiquel Comas, Endocrinólogo. Hospital Son Llàtzer (Palma de Mallorca)
Hurdles and new players in the management of chronic heart failure with reduc...Dhritisdiary
Watch the slideshow for a better understanding: https://youtu.be/CsXvS1hA330
1. Learn the standard therapy in HFrEF
2. Learn its challenges
3. Learn the new drugs for HFrEF.
La aterosclerosis como enfermedad sistémica una visión integral de la enfermedad cardiovascular
Miércoles, 22/06/16 18:00h-20:00h Casa del Corazón, Madrid
http://cvvt.secardiologia.es
#CVVT
La enfermedad aterosclerótica en neurología: particularidades y novedades
Dr. Carlos Molina Cateriano, Hospital Universitari Vall d'Hebron, Barcelona
Association and prevalence of different comorbidities in hypertension and management with focus guidelines with benefits & choice of different antihypertensives in different comorbidities.
Challenges in management of peripartum cardiomyopathy with diuretic resistanc...iosrphr_editor
presentation: In this report we present a 30 years old female patient, Para 1 living 1, who was admitted one month ago with complaints of abdominal distension, lower limb swelling and difficulty in breathing that started worsening two weeks prior.12-lead ECG showed sinus tachycardia (100beats/min), low voltage and non-specific T inversion and flattening.Echocardiography showed dilated left ventricle (5.8cm) and left atrium (4.4cm), global hypokinesia with ejection fraction of 36% by biplane. Grade 1 diastolic dysfunction, no thrombus seenand Mild pericardial effusion.
Challenges in management of peripartum cardiomyopathy with diuretic resistanc...iosrphr_editor
Background: Peri-partum cardiomyopathy is an idiopathic cardiomyopathy that presents with heart failure secondary to left ventricle systolic dysfunction towards the end of pregnancy or in the months after delivery, in the absence of any other cause of heart failure.Approximately 75% of cases are diagnosed within the first month peri-partum, and 45% present in the first week. Case
Similar to Exacerbation of Heart Failure : Thiazolidinediones (20)
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Exacerbation of Heart Failure : Thiazolidinediones
1. Nathalie M. Merle
PharmD Student
University of Florida
September 24, 2003
Exacerbation of Heart Failure:
Thiazolidinediones
2. Overview
Heart Failure
Insulin Resistance
Thiazolidinediones
Case Reports
Alternative Therapy
Conclusion
3. Heart Failure
“A complex clinical syndrome that can result from
any structural or functional cardiac disorder that
impairs the ability of the ventricle to fill with or
eject blood.”1
4. Epidemiology2
5 million Americans in 1996
10 million expected in 2007
400,000 – 700,000 new diagnosis / year
Nearly 300,000 deaths / year
In 1991 > 2 million hospitalizations
HF management = $56 billion in 1996
8. NYHA Functional Classification
Class I
No limitations of physical activity
Class II
Slight limitations of physical activity
Class III
Marked limitation of physical activity
Class IV
Symptoms present at rest / exacerbated upon physical activity
10. High Risk Groups2
Systemic Hypertension
Coronary Artery Disease
Diabetes Mellitus
History of cardiotoxic drugs
Rheumatic fever
Family history of cardiomyopathy
17. Actos® Pioglitazone6
& Avandia® Rosiglitazone7
Warnings
Fluid retention; may exacerbate or lead to HF.
Combination with insulin may risk of CV adverse events.
Discontinue if deterioration in cardiac status.
NYHA Class III/IV not studied during clinical trials. Not
Recommended.
Renal Impairment
No dosage adjustment.
18. Preexisting Medical Conditions6,7
Avandia: 26 Wk-Study Actos: 16 Wk-Study
216 pts Avandia 4mg / Insulin 191 on Actos 15mg / Insulin
322 pts Avandia 8mg / Insulin 188 on Actos 30mg / Insulin
388 pts Insulin 187 on Insulin
Distribution of preexisting Distribution: 2.3% CHF (13
medical conditions not pts)
disclosed 4 pts CHF (0.01%)
edema and HF with combo History of CVD
19. Edema, Weight Gain, and Anemia6,7
Avandia: 26 Wk-Study Actos: 16 Wk-Study
Significant Volplasma Weight Gain:
Weight Gain: Δ 1.0 Kg on 30 mg
Δ 3.1 Kg on 8 mg Δ 0.9 Kg on 15 mg
Δ 1.0 Kg on 4 mg Hematology: 4 -12 weeks
Hematology: 3 months 2-4% Hgb
1.0 gm/dL Hgb
3.3% Hct
21. Patients and Methods
648 patients treated with TZD
28% Actos® pioglitazone
72% Avandia® rosiglitazone
Retrospective chart review
6 male NYHA I-II patients
New onset CHF and pulmonary edema (PE)
Recent TZD initiation
Duration 1-16 months
Dose 3 weeks to 3 months
TZD discontinued / diuretics administered
22. Clinical Characteristics
No Preexisting CHF NYHA II CHF
66-78 years of age 67 years old
Diabetes: 4-21 years Diabetes: 20 years
All 5 on Rosiglitazone Pioglitazone
Max Dose (8 mg): 4 out of 5 Max Dose (45 mg)
TZD duration: 1, 6, 8,16 months TZD duration: 7 months
Weight gain (Kg): 1, 5, 6, 9, 12 Weight gain: 8 kg
Insulin, glyburide, glipizide Insulin
3 Hospitalization Hospitalization
23. Results and Discussion
No acute cardiac event explaining deterioration
Renal Insufficiency: 4 cases
Ischemic Cardiomyopathy: 1 case
Signs/symptoms resolved in all 6 with d/c of TZD
6 cases ~ 0.9% of TZD-treated population
Authors conclude
NYHA I or II ~ risk for TZD-associated HF
Canadian Adverse Reaction Monitoring Program: 9
reports HF and PE due to TZD6,7
24. ACC/AHA Guidelines1
“Diabetics with HF have worse prognosis”
“It is prudent to manage,…, DM in patients with HF
as if the patients did not have HF”
“Thiazolidinediones should be used with caution in
such patients”
26. Recommendations for MGMT
ALERT: Dose Titration
3 months after TZD initiation (HbA1c response)
ALERT: MDD
Avandia (8mg); Actos (45mg)
Cardiologist - Endocrinologist Communication
Edema and Weight Gain
TZD dose adjustment
Switch to a TZD associated with less weight gain
Caution against TZD - insulin combination4,5,7
Diuretic Resistance d/c TZD
Educate patient on early recognition of fluid overload
27. Conclusion
1/3 of HF patients have DM1
6 million Diabetics: Actos® or Avandia®
HF and Insulin Resistance
TZD enhance insulin sensitivity
Case Reports6: TZD HF
Max Dose: 5 out of 6 patients
Dose Increase: 3 weeks to 3 months
Establish mechanism of action for fluid retention
Long term clinical trials
28. Recommended Readings
Wang CH, Weisel RD, Liu PP, Fedak PWM, Verma SV. Glitazones
and Heart Failure: Critical Appraisal for the Clinician. Circulation
2003; 107; 1350-1354
Swan JW, Anker ST, Walton C, Godsland IF, et al. Insulin
Resistance in Chronic Heart Failure: Relation to Severity and
Etiology of Heart Failure.
29. References
1 American College of Cardiology [resource on World Wide Web]. URL:
http://www.acc.org. ACC/AHA Guidelines for the Evaluation and
Management of Chronic Heart Failure in the Adult. Available from the
internet. Accessed 2003, Sept 10.
2 Johnson JA, Parker RB, Patterson JH. Heart Failure. In Pharmacotherapy: A
Pathophysiologic Approach. 5th ed. Dipiro JT, Talbert RL, Yee GC et al., eds.
New York: McGraw-Hill; 2002;185-218
3 AACE Medical Guidelines for the Management of Diabetes Mellitus: The
AACE System of Intensive Diabetes Self-Management. Endocrine Practice
2002;8;40-65
4 Wang CH, Weisel RD, Liu PP, Fedak PWM, Verma SV. Glitazones and
Heart Failure: Critical Appraisal for the Clinician. Circulation 2003; 107;
1350-1354
5 Wilson Tang WH, Francis GS, Hoogwerf BJ, Young JB. Fluid Retention
After Initiation of Thiazolidinediones Therapy in Diabetic Patients with
Established Chronic Heart Failure. JACC 2003; 41(8); 1394-1398
6 Actos® prescribing information. Lincolnshire, IL: Takeda Pharmaceuticals
North America, Inc; 2002 July
30. References
7 Avandia® prescribing information. Research Triangle Park, NC:
GlaxoSmithKline; 2003 March
8 Kermani A, Garg A. Thiazolidinedione-Associated Congestive Heart Failure and
Pulmonary Edema. Mayo Clinic Proceedings 2003;78;1088-1091
9 Wooltorton E. Rosiglitazone (Avandia) and Pioglitazone (Actos) and heart
failure. CMAJ. 2002;166(2)219. Editorial.
10 Swan JW, Anker ST, Walton C, Godsland IF, et al. Insulin Resistance in Chronic
Heart Failure: Relation to Severity and Etiology of Heart Failure.
11 Creager MA, Luscher TF. Diabetes and Vascular Disease Pathophysiology,
Clinical Consequences, and Medical Therapy: Part 1. Circulation 2003; 108:
1527-1532
12 Oki JC, Isley WL. Diabetes Mellitus. In Pharmacotherapy: A Pathophysiologic
Approach. 5th ed. Dipiro JT, Talbert RL, Yee GC et al., eds. New York: McGraw-
Hill; 2002;1335-1358
13 Page II RL, Gonzansky WS, Ruscin JM. Possible Heart Failure Exacerbation
Associated with Rosiglitazone: Case Report and Literature Review.
Pharmacotherapy 2003; 23(7): 945-954
31. References
14 Nichols GA, Hiller TA, Erbey JR, Brown JB. Congestive Heart Failure in
Type 2 Diabetes: Prevalence, Incidence, and Risk Factors. Diabetes Care
2001;24(9);1614-1619
15 Davis SN, Granner DK. Insulin, Oral Hypoglycemic Agents, and the
Pharmacology of the Pancreas. In Goodman and Gilman’s the
Pharmacological Basis of the Therapeutics. 10th ed. Hardman JG, Limbrid
LE, Gilman AG. New York: McGraw-Hill; 2001;1679-1714
16 Actos®-Congestive Heart Failure. Medical Services Department of Takeda
Pharmaceuticals North America. Facsimile received 2003, Sept 18.
32. Management of Fluid Status1
Goal
Stable
Euvolemia
Status of Renal Perfusion
Low doses of loop diuretics / dietary sodium restriction
loop diuretics add 2nd diuretic (metolazone)
High dose IV diuretics +/- IV dopamine or dobutamine
Ultrafiltration or hemofiltration
33. Insulin Edema
Rare complication
Frequently seen earlier years of insulin therapy
Mostly seen when dysregulated patients with progressive
weight loss are treated with relatively high amounts of insulin
May aggravate pulmonary edema, CHF, HTN
Treatment: insulin dose; edema subsidizes 3-4 days
34. Sulfonylureas
Glimepiride, Glipizide, Glyburide
Mode of Action
1o: insulin secretion by // K+ channel
2o: hepatic glucose production
Contraindications
Hypersensitivity, DK, sulfa allergy
Adverse Effects
Hypoglycemia, hypersensitivity, weight gain
35. Meglitinides
Prandin® Repaglinide, Starlix® Nateglinide
Mode of Action
1o: BG by releases insulin in response to meals
2o: FBG and PPBG
Contraindications
Diabetic Ketoacidosis, hypersensitivity
Adverse Effects
Hypoglycemia, weight gain
36. α-Glucosidase Inhibitors
Precose® Acarbose, Glyset® Miglitol
Mode of Action
Inhibits enzyme in SI to slow digestion of carbohydrates, delay
glucose absorption, and reduce in PPBG
Contraindications
GI disorders, chronic ulceration, malabsorption, or intestinal
obstruction
Adverse Effects
Flatulence and abdominal bloating